This metabolite incorporates a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 about fifty% of the dad or mum drug. Plasma concentrations of this metabolite are close to 40% of Those people seen for sildenafil, so the metabolite accounts for around 20% of sildenafil's pharmacologic results.Your browser isn’t support